Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor AP-2 delta (TFAP2D) is a protein-coding gene that encodes a sequence-specific DNA-binding transcription factor[1][2][3][7]. It regulates gene transcription by interacting with viral and cellular enhancer elements, binding to the consensus sequence 5'-GCCNNNGGC-3', and activating or repressing gene expression involved in critical biological processes such as cell proliferation and developmental pathways[1][3][7]. TFAP2D is implicated in transcriptional regulation, cell population proliferation, and neuronal development, and has been associated with diseases including cancer, Char syndrome, and branchiooculofacial syndrome[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor AP-2 delta (TFAP2D).